Benitec Biopharma Announces Appointment of Sharon Mates Ph.D. to its Board of Directors
Globenewswire· 2025-11-03 20:00
-Dr. Mates served as the Chairman, Chief Executive Officer, and Co-founder of Intra-Cellular Therapies, a mental health company, from June 2002 until it was acquired by Johnson & Johnson in 2025-HAYWARD, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec” or “Company”), a clinical-stage, gene therapy-focused, biotechnology company developing novel genetic medicines based on its proprietary “Silence and Replace” DNA-directed RNA interference (“ddRNAi”) platform, today a ...
BioCryst Reports Third Quarter 2025 Financial Results and Provides Business Update
Globenewswire· 2025-11-03 20:00
—Q3 2025 ORLADEYO net revenue of $159.1 million (+37 percent y-o-y)— —Q3 2025 operating profit of $29.6 million (+285 percent y-o-y); non-GAAP operating profit of $51.7 million (+107 percent y-o-y); continued improvement in non-GAAP operating profit margin from strong operating leverage— —ORLADEYO FY 2025 revenue guidance raised to between $590 to $600 million; FY 2025 non-GAAP operating expense guidance lowered to between $430 to $440 million— —Sale of European ORLADEYO business completed; proceeds used ...
Luckin Coffee to Announce Third Quarter 2025 Financial Results on November 17, 2025
Globenewswire· 2025-11-03 20:00
BEIJING, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Luckin Coffee Inc. (“Luckin Coffee” or the “Company”) (OTC: LKNCY) will release its third quarter 2025 financial results before the U.S. market opens on Monday, November 17, 2025. The Company will hold a conference call on Monday, November 17, 2025 at 8:00 am Eastern Time (or Monday, November 17, 2025 at 9:00 pm Beijing Time) to discuss the financial results and take questions live. Participants may access the call by dialing the following numbers: United States To ...
ECARX Announces Third Quarter 2025 Unaudited Financial Results
Globenewswire· 2025-11-03 20:00
LONDON, Nov. 03, 2025 (GLOBE NEWSWIRE) -- ECARX Holdings Inc. (Nasdaq: ECX) (“ECARX” or the “Company”), a global mobility tech provider, today announced unaudited financial results for the quarter ended September 30, 2025. Ziyu Shen, ECARX Chairman and CEO, commented, “The strong momentum from the first half of the year carried through into Q3, delivering several significant milestones that are reinforcing the sustainable foundation we are building for future growth. Most notably, we achieved EBITDA breakev ...
Flagship Communities Real Estate Investment Trust Expands Presence in Key Markets
Globenewswire· 2025-11-03 20:00
ACQUIRES FOUR COMMUNITIES IN INDIANA AND OHIO FOR TOTAL CONSIDERATION OF US$79 MILLIONNot for distribution to U.S. newswire services or dissemination in the United States. TORONTO, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Flagship Communities Real Estate Investment Trust (TSX:MHC.U) (TSX:MHC.UN) (“Flagship” or the “REIT”) today announced two strategic acquisitions for total consideration of US$79 million, expanding its presence in both Indiana and Ohio (the “Acquisitions”). The Acquisitions are expected to be imme ...
OTC Markets Group Welcomes Meren Energy Inc. to OTCQX
Globenewswire· 2025-11-03 20:00
公司升级事件 - Meren Energy Inc 从 Pink Limited™ 市场升级至 OTCQX® 最佳市场并开始交易 交易代码为 "MRNFF" [1][2] - 公司升级旨在为美国投资者提供更透明的交易环境 反映其对透明度、良好治理和积极与投资界互动的承诺 [3][4] 公司业务概览 - Meren Energy Inc 是一家全周期独立上游油气公司 业务离岸分布于尼日利亚、纳米比亚、南非和赤道几内亚 [4] - 公司主要资产为在尼日利亚深水由大型运营商运营的生产和开发资产 并在包括纳米比亚维纳斯轻油项目在内的奥兰治盆地占据领先地位 [4] 市场运营方信息 - OTC Markets Group Inc 运营着供12,000种美国和国际证券交易的受监管市场 其数据驱动的披露标准构成公共市场基础 [5] - 其OTC Link®替代性交易系统为经纪商提供关键的市场基础设施 创新模型为公司更高效进入美国金融市场提供途径 [5]
Caribou Biosciences Announces Positive Data from CaMMouflage Phase 1 Trial of CB-011 in Multiple Myeloma
Globenewswire· 2025-11-03 20:00
First clinical data disclosure for CB-011 highlights its potential as a best-in-class allogeneic CAR-T cell therapy for relapsed or refractory multiple myeloma450 million cell dose is the recommended dose for expansion (RDE); dose expansion to initiate by year end and data expected in 202692% ORR, 75% ≥CR rate, 91% MRD negativity in the 12-patient, BCMA-naïve cohort treated at the RDE with the selected lymphodepletion regimenConference call and webcast scheduled for today at 8:00 am ET BERKELEY, Calif., Nov ...
Xanadu Expected to Become the First and Only Publicly Traded Pure-Play Photonic Quantum Computing Company via Business Combination with Crane Harbor Acquisition Corp.
Globenewswire· 2025-11-03 20:00
Xanadu Produced the First Networked, Modular and Scalable Quantum Computer with their Aurora System in Early 20251First Pure Play Quantum Computing Company to Achieve Quantum Supremacy with their Borealis System in 2022 Xanadu’s PennyLane Software Offering is the #1 Quantum Programming Software with 47% Usage Among Quantum Programmers2Pro Forma Enterprise Value of the Combined Company is Expected to be Approximately US$3.1 Billion and Pro Forma Market Capitalization is Expected to be Approximately US$3.6 Bi ...
Gogo begins flight testing next-generation air-to-ground connectivity with 5G chip and Gogo AVANCE LX5 and Gogo X3 products.
Globenewswire· 2025-11-03 20:00
First successful end-to-end on-wing calls already completed. Gogo begins flight testing next-generation 5G ATG connectivity on Pilatus PC-24 jet MB-13 antennas equipped to belly of the fuselage connect with the Gogo 5G tower network Broomfield, CO., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Gogo (NASDAQ: GOGO) has begun flight testing its next-generation 5G air-to-ground connectivity network for North American customers. Optimizing a Pilatus PC-24 trials platform, the test team is flying on alternate days during ...
Schouw & Co. share buy-back programme, week 44 2025
Globenewswire· 2025-11-03 20:00
On 5 May 2025, Schouw & Co. initiated a share buy-back programme as outlined in Company Announcement no. 20 of 2 May 2025. Under the programme, Schouw & Co. will acquire shares for up to DKK 120 million during the period 5 May to 31 December 2025. The buy-back will be structured in accordance with Regulation (EU) No. 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (MAR) and the Commission’s delegated regulation (EU) 2016/1052 of 8 March 2016 (“Safe Harbour” rules). Tr ...